As clinicians begin to rely more on AI, they will also need to cultivate new skills, particularly around critical interpretation of AI-generated insights, to fully leverage its potential in patient care. The post From Crawling to Caring: The Evolution of Clinical Practice with AI and Its Transformative Impact on Healthcare appeared first on MedCity News.
Novo Holdings led the Series A investment in Kivu Biosciences, developer of next-generation antibody drug conjugates for solid tumors. The startup’s ADCs and technology were licensed from Synaffix, a Lonza subsidiary. The post Precision Oncology Startup Kivu Unveils $92M for More Stable & Durable ADC Cancer Drugs appeared first on MedCity News.
The status quo is simply untenable for many companies as health insurance costs spiral. From family-owned businesses to large enterprises, employers are taking advantage of an alternative designed by politicians on both sides of the aisle. The post How a Bipartisan Program Can Help You Avoid Costly Health Insurance Renewals appeared first on MedCity News.
This analysis examines the competitiveness of markets for hospital care based on the share of metropolitan areas controlled by a small number of independent hospitals or health systems and other measures. It finds that nearly half of metropolitan areas across the country had only one or two hospitals or health systems providing general inpatient hospital…
Healthcare affordability continues to decline as patients struggle with rising healthcare costs. Roughly half of U.S. adults report struggling to pay their medical bills. Patients are also frustrated with the lack of cost transparency, inaccurate estimates and confusion around what insurance covers and what’s owed out of pocket. When there’s a lack of understanding about…
Like any other tool, understanding the right problem to apply it to is the difference between success and failure. Addressing a problem is never just about technology; it’s always about people, processes, and technology. The post The AI Advantage: Reimagining the Future of Drug Development appeared first on MedCity News.
Pieces Technologies’ conversational AI tool allows cancer patients to ask questions about their care, while simultaneously ascertaining information about social determinants of health
Veteran California public servant Will Lightbourne has stepped in as interim executive director of the state’s mental health commission after its previous executive director resigned following conflict of interest allegations. Lightbourne served as head of the state’s Department of Social Services for seven years before retiring in 2018 and had already returned to service once,…
KFF’s Survey of Medicaid Financial Eligibility for Older Adults & People with Disabilities, conducted in March 2025 by KFF and Watts Health Policy Consulting, provides a baseline of Medicaid eligibility as states return to normal operations after the end of the COVID-19 pandemic and ahead of potential changes to the Medicaid program.
The weight loss results for the Terns Pharmaceuticals drug TERN-601 come from a four-week Phase 1 clinical trial. Terns is one of several companies developing oral GLP-1 obesity medications that could become alternatives to currently available injectable products from this drug class. The post Terns Pharma Oral GLP-1 Drug Leads to Greater Than 5% Weight…